Despite a 5.3% return over the past year, the company's falling revenue and loss-making status pose investment risks. There are 4 warning signs despite some signs of improvement.
Concerns about the company's profitability and revenue growth have led to a sharp decline in its stock value. Despite dividend-boosted TSR, long-term shareholders incur losses. Significant improvements in key metrics may stir investor interest in the stock.
ブライトスパイア・キャピタルに関するコメント
コラムToday's Pre-Market Stock Movers: TSLA, F, KORE, AMLX and More
In reaction to earnings/guidance:
$RPMインターナショナル(RPM.US)$ +2.4%
Other news:
$ラディアント・ロジスティクス(RLGT.US)$ +6.8% (to restate FY21 earnings)
$Stellus Capital Investment(SCM.US)$ +3.3% (declares Q4 dividends of $0.34 per share)
$ゴールデン・オーシャン・グループ(GOGL.US)$ +2.5% (authorizes new $100 mln share repurchase program)
$iPath Series B S&P 500 VIX Short-Term Futures ETN(VXX.US)$ +1.5% (rising with pull back in stock futures)
$ペブルブルーク・ホテル・トラスト(PEB.US)$ +1.3% (se...
コラムToday's pre-market stock movers: KR, REV, RACE, PHG and more
• $アケロ・セラピューティクス(AKRO.US)$ +9.6% (announces two financing transactions with Pfizer (PFE) and Hercules Capital (HTGC) providing access to up to $125 million)
• $ブライトスパイア・キャピタル(BRSP.US)$ +6.3% (increases dividend)
• $カロバイオス・ファーマシューティカルズ(HGEN.US)$ +4% (entered into an agreement with PCI Pharma Services as part of preparations for commercialization in the United Kingdom)
• $アリソン・トランスミッション・ホールディングス(ALSN.US)$ +2.8% (electric hybrid bu...
まだコメントはありません